Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275686 · ClinicalTrials.gov registry record · Phase 2
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
A Phase 2 study of Eustachian Tube Dysfunction, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 4
- Study locations
NCT05275686 is a Phase 2 study of Eustachian Tube Dysfunction that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 80 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT05275686, a Phase 2 study of Eustachian Tube Dysfunction, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 4
- Study locations
Study Summary
Intranasal nasal steroid sprays are the mainstay of treatment for chronic Eustachian tube dysfunction despite having little supportive evidence in the literature. A novel, commercially available nasal spray delivery system is available now for fluticasone that improves its delivery to the nasopharynx. The hypothesis of this study is that fluticasone using the novel spray system is effective for Eustachian tube dysfunction (ETD).
Conditions Studied
Interventions
- DRUG Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray
- OTHER Placebo Nasal Spray
Study Locations (4)
California
- Cedars-Sinai Medical Center - Los Angeles
- Sacramento Ear, Nose & Throat - Sacramento
Indiana
- Indiana University - Indianapolis
Louisiana
- Ochsner Health System - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05275686
The ClinicalTrials.gov registry entry for NCT05275686 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eustachian Tube Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray is the first listed.
NCT05275686 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Indiana, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05275686 about?
NCT05275686 is a clinical study titled "Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)". Intranasal nasal steroid sprays are the mainstay of treatment for chronic Eustachian tube dysfunction despite having little supportive evidence in the literature. A novel, commercially available nasal spray delivery system is available now for fluticasone that improves its delivery to the nasopharyn...
What is the current status of trial NCT05275686?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2022-04-20. Estimated completion is 2027-12-31.
What conditions does trial NCT05275686 study?
This clinical trial studies the following conditions: Eustachian Tube Dysfunction.
What interventions are being tested in trial NCT05275686?
The interventions under investigation include: Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray (DRUG), Placebo Nasal Spray (OTHER).
Who is sponsoring clinical trial NCT05275686?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05275686 being conducted?
This trial has 4 study locations across California, Indiana, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eustachian Tube Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.